Duke University Medical Center /ID# 279457

Durham, North Carolina 27710

1 studies enrolling now · 1 studies all time

What they study most

Colorectal Cancer

Studies at this site

• A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease — Recruiting now